ECE 2023
When should zoledronate be administered after denosumab?
www.high5endocrinology.tv | Meeting coverage | ECE 2023
ECE 2023
When should zoledronate be administered after…
ECE 2023
Thiazide challenge test
ECE 2023
Risk factors for non-genetic osteoporosis
ECE 2023
News on hypoparathyroidism
ECE 2023
Primary hyperparathyroidism - difficulties in finding…
ECE 2023
Parathyroid hormone - overview and new horizons
ECE 2023
Why acts denozumab stronger than zoledronic acid?
ECE 2023
New therapy for hypoparathyroidism
ECE 2023
Pitfalls in interpreting vitamin D studies
ECE 2023
Therapy in medullary thyroid carcinoma
ECE 2023
Overtreatment of differentiated thyroid carcinomas
ECE 2023
Treatment of thyroid eye disease
ECE 2023
Management of thyroid eye disease
ECE 2023
Frequency of thyroid carcinoma recurrence
ECE 2023
News on the therapy of neuroendocrine tumors
ECE 2023
No alpha blockage for pheochromocytoma surgery
ECE 2023
Therapy options for pheochromocytoma
ECE 2023
News about paraganglioma
ECE 2023
Complex hormonal syndromes
ECE 2023
WHO classification of neuroendocrine tumors
ECE 2023
Chronotherapy in CAH
ECE 2023
Oxytocin deficiency in patients with diabetes insipidus
ECE 2023
Care of childhood cancer survivors
ECE 2023
Transferring the knowledge of parents to patients in…
ECE 2023
Growth hormone and cancer - Laron syndrome
ECE 2023
Diabetes insipidus - diagnostic challenges
ECE 2023
Cortisol from salivary
ECE 2023
Growth hormone and cancer - animal models
ECE 2023
Growth hormone from filter paper
ECE 2023
Effects of endocrine disruptors
ECE 2023
EDCs and obesity
ECE 2023
Research in rare endocrine diseases
ECE 2023
The endocrinology of stress - Transatlantic Alliance…
ECE 2023
Efficacy of self-resolving screws in fracture healing
ECE 2023
Adolescent transgender care
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!